BROWSING:    SCD

Sidra Medicine has been qualified by Vertex Pharmaceuticals to administer Casgevy, a groundbreaking, one-time CRISPR/Cas9-based gene therapy treatment. Image Courtesy: Sidra Medicine
Read More

LATEST POSTS

What a Coffee Mug Taught Economists About Ownership
Trade Shows, Client Visits and Visas How Smart UAE Companies Plan Q4 Travel
Image Courtesy By WSFunded
IFA World Franchise Show Banner